Medical devices to deliver transcutaneous electrical stimulation using interferential current to treat constipation

Southwell, Bridget R.

doi:10.1586/17434440.2013.855507

Cited by 6 publications

(10 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interferential (IF) current is a type of electrical stimulation that uses two medium‐frequency alternating currents to generate a low frequency beat effect in the tissue . IF electrical stimulation (IFES) has been previously used to augment the strength of pelvic floor and deep skeletal muscles in adults , and has also shown benefits in decreasing constipation symptoms in children with slow transit constipation . IFES has also been used for women with stress UI .…”

Section: Introductionmentioning

confidence: 99%

Transcutaneous interferential electrical stimulation for the management of non‐neuropathic underactive bladder in children: a randomised clinical trial

et al. 2015

View full text Add to dashboard Cite

ObjectivesTo assess the efficacy of transcutaneous interferential electrical stimulation (IFES) and urotherapy in the management of non-neuropathic underactive bladder (UAB) in children with voiding dysfunction. Patients and MethodsIn all, 36 children with UAB without neuropathic disease [15 boys, 21 girls; mean (SD) age 8.9 (2.6) years] were enrolled and then randomly allocated to two equal treatment groups comprising IFES and control groups. The control group underwent only standard urotherapy comprising diet, hydration, scheduled voiding, toilet training, and pelvic floor and abdominal muscles relaxation. Children in the IFES group likewise underwent standard urotherapy and also received IFES. Children in both groups underwent a 15-session treatment programme twice a week. A complete voiding and bowel habit diary was completed by parents before, after treatment, and 1 year later. Bladder ultrasound and uroflowmetry/electromyography were performed before, at the end of treatment course, and at the 1-year follow-up. ResultsThe mean (SD) number of voiding episodes before treatment was 2.6 (1) and 2.7 (0.76) times/day in the IFES and control groups, respectively, which significantly increased after IFES therapy in IFES group, compared with only standard urotherapy in the control group [6.3 (1.4) vs 4.7 (1.3) times/ day, P < 0.002). The mean (SD) bladder capacity before treatment was 424 (123) and 463 (121) mL in the control and IFES groups, respectively, which decreased significantly at 1 year after treatment in the IFES group compared with the controls, at 227 (86) vs 344 (127) mL (P < 0.01). Maximum urine flow increased and voiding time decreased significantly in the IFES group compared with controls at the end of treatment sessions and 1 year later (P < 0.05). All the children had abnormal flow curves at the beginning of the study. The flow curve became normal in 14/18 (77%) of the children in the IFES group and six of 18 (33%) in the control group by the end of follow-up (P < 0.007). At the end of the treatment course, night-time wetting was improved in all children who had this symptom before the treatment in the IFES group (P < 0.01). ConclusionCombining IFES and urotherapy is a safe and effective therapy in the management of children with UAB.

show abstract

Section: Introductionmentioning

confidence: 99%

Transcutaneous interferential electrical stimulation for the management of non‐neuropathic underactive bladder in children: a randomised clinical trial

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Patients in the IFC group were given a treatment cycle of 14 sessions over 2 weeks, which is similar to a previous study. 12 Judging by the preliminary results, after undergoing this treatment cycle, our research testified that this therapy duration yielded a satisfactory outcome. Whether a longer treatment cycle would achieve more efficacy needs to be clarified in the future.…”

Section: Discussionmentioning

confidence: 78%

“…Hence, we concentrated on Tianshu and Zhongwan acupoints in our study temporarily; other positions might be considered in our next step. Similar to other literature, 12 the IFC frequency in our study was also set to 4 kHz, with an adjustable intensity and a beat frequency sweep covering 80 to 120 Hz. The intensity of the stimulator was increased gradually until the patient reported that a further rise would cause discomfort.…”

Section: Discussionmentioning

confidence: 99%

“…Improvements have been confirmed at different frequencies on different positions on the body’s surface. 12 According to TCM, the acupoints responsible for the GI system primarily contain He-Sea acupoints, Front-Mu acupoints, and Back-Shu acupoints. At present, no definite conclusion has been arrived at yet on which acupoints are optimal stimulation positions or the specific location of neuroregulation (IFC or electroacupuncture).…”

Section: Discussionmentioning

confidence: 99%

“… 3 , 10 In recent years, acupuncture and electroacupuncture have been confirmed as effective in the management of GI motility disorders, such as chronic treatment-resistant constipation. 11 , 12 Compared with traditional acupuncture and electrical acupuncture, transcutaneous acupoint interferential current (IFC) therapy has the advantage of being noninvasive as well as amenable to adjustability of stimulation frequency and intensity objectively and quantifiably; therefore, it is increasingly being applied in various GI diseases. 13 - 16 In this study, we assess transcutaneous acupoint IFC stimulation with pad electrodes on the belly (acupoints ST25 and RN12) in cancer pain patients with OIC, compared with oral lactulose administration, to observe its efficacy and safety in this population.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The Efficacy and Safety of Transcutaneous Acupoint Interferential Current Stimulation for Cancer Pain Patients With Opioid-Induced Constipation: A Prospective Randomized Controlled Study

Zhu

Gong

et al. 2017

Integr Cancer Ther

View full text Add to dashboard Cite

Introduction. Opioid-induced constipation (OIC) is a principal complication secondary to analgesic therapy for cancer pain patients who suffer moderate to severe pain. In this study, we observe the efficacy and safety of transcutaneous acupoint interferential current (IFC) stimulation in those patients with OIC. Methods. A total of 198 patients were randomly allocated to the IFC group and control group in a 1:1 ratio. Finally, 98 patients in the IFC group received 14 sessions administered over 2 weeks, whereas 100 patients in the control group took lactulose orally during the same period. Observation items were documented at management stage and at follow-up stage according to Cleveland Constipation Scales (CCS), pain Numeric Rating Scales (NRS) and Patient Assessment of Constipation Quality of Life (PAC-QoL). Results. The total curative effects of the IFC group and the control group were indistinguishable (76.5% vs 70.0%, P = .299). Regarding CCS and PAC-QoL scores, no significant difference was observed between the 2 groups during the management time and at the follow-up stage of week 3 (P > .05, respectively), but groups were distinguished at the follow-up stage of week 4 (P < .001 and P = .031, respectively). The pain NRS decreased significantly at management stage week 2 and follow-up stage week 3 and week 4 (P = .013, P = .041, P = .011, respectively). Conclusions. Transcutaneous acupoint IFC therapy over acupoints of Tianshu (ST25) and Zhongwan (RN12) may improve constipation and quality of life in cancer patients receiving opiates; further studies are worthwhile.

show abstract

Impact of transcutaneous interferential electrical stimulation for management of primary bladder neck dysfunction in children

Sharifi‐Rad

Ladi‐Seyedian

Fatemi-Behbahani

et al. 2020

Journal of Pediatric Urology

View full text Add to dashboard Cite

Medical devices to deliver transcutaneous electrical stimulation using interferential current to treat constipation

Cited by 6 publications

References 21 publications

Transcutaneous interferential electrical stimulation for the management of non‐neuropathic underactive bladder in children: a randomised clinical trial

Transcutaneous interferential electrical stimulation for the management of non‐neuropathic underactive bladder in children: a randomised clinical trial

The Efficacy and Safety of Transcutaneous Acupoint Interferential Current Stimulation for Cancer Pain Patients With Opioid-Induced Constipation: A Prospective Randomized Controlled Study

Impact of transcutaneous interferential electrical stimulation for management of primary bladder neck dysfunction in children

Contact Info

Product

Resources

About